Eveliqure and Serum Institute of India Announce Strategic Collaboration on the Development of Anti-Diarrhoeal Vaccines
VIENNA, AUSTRIA, March 20, 2026 /EINPresswire.com/ -- Eveliqure Biotechnologies GmbH, a clinical-stage biotechnology company focused on Shigella and ETEC vaccine development, and Serum Institute of India (SII), a Cyrus Poonawalla group company …